v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash $ 1,406,691
Prepaid expenses 163,124 59,999
Total Current Assets 1,569,815 59,999
Deferred offering costs 252,543
Cash Held in Trust Account 126,658,210
Total Assets 128,228,025 312,542
Current Liabilities:    
Accrued formation and offering costs 58,159
Accounts payable 5,831
Sponsor advance 275,875
Total Current Liabilities 5,831 334,034
Commitments and contingencies (Note 6)  
Class A Ordinary Share, $0.0001 par value; 12,515,000 and 0 shares subject to possible redemption at $10.12 and $0.00 per share at June 30, 2026 and December 31, 2025, respectively 126,658,210
Shareholders’ Equity (Deficit):    
Preferred shares, $0.0001 par value; 20,000,000 shares authorized; none issued or outstanding
Additional paid-in capital 265,111 24,521
Retained Earnings (Accumulated deficit) 1,298,425 (46,492)
Total Shareholders’ Equity (Deficit) 1,563,984 (21,492)
Total Liabilities and Shareholders’ Equity (Deficit) 128,228,025 312,542
Common Class A [Member]    
Shareholders’ Equity (Deficit):    
Ordinary shares, value 31
Common Class B [Member]    
Shareholders’ Equity (Deficit):    
Ordinary shares, value [1] $ 417 $ 479
[1] As of December 31, 2025, includes 625,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). Shares and associated accounts have been retroactively restated to reflect the surrender of 958,333 Class B ordinary shares for no consideration on February 23, 2026. On February 26, 2026, the underwriters partially exercised their over-allotment option and purchased an additional 15,000 units at the public offering price (see note 7). The underwriters did not exercise the remaining portion of the over-allotment option, and the option expired unexercised at the end of the 45-day period following the closing of the Initial Public Offering. As a result, 620,000 Class B ordinary shares were surrendered on April 11, 2026.